Cellectis (CLLS) Total Debt (2014 - 2026)
Cellectis (CLLS) recorded quarterly Total Debt of $76.4 million in Q1 2026, down 9.55% quarter-over-quarter from $84.5 million in Q4 2025, and up 12.65% on a YoY basis from $67.8 million in Q1 2025.
Cellectis (CLLS) Total Debt (2014 - 2026) Analysis & Trends
Cellectis' Total Debt history runs 13 years deep, the most recent figure standing at $76.4 million for Q1 2026.
- In Q1 2026, Total Debt rose 12.65% year-over-year to $76.4 million; the TTM figure through Mar 2026 stood at $76.4 million (up 12.65% YoY), while the FY2025 annual figure was $84.5 million, up 26.05% from the prior year.
- Total Debt was $76.4 million for Q1 2026 at Cellectis, down from $84.5 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $84.5 million in Q4 2025 to a low of $24.8 million in Q1 2023.
- Historically, Total Debt has averaged $54.8 million across 5 years, with a median of $63.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Total Debt declined 19.83% in 2023, then soared 173.21% in 2024.
- A 5-year view of Total Debt shows it stood at $25.6 million in 2022, then jumped by 112.4% to $54.4 million in 2023, then increased by 23.16% to $67.0 million in 2024, then climbed by 26.05% to $84.5 million in 2025, then slipped by 9.55% to $76.4 million in 2026.
- The last three Total Debt figures came in at $76.4 million (Q1 2026), $84.5 million (Q4 2025), and $81.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | 76.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.40 Mn |
| Dec 31, 2025 | 84.47 Mn |
| Sep 30, 2025 | 81.64 Mn |
| Jun 30, 2025 | 74.09 Mn |
| Mar 31, 2025 | 67.82 Mn |
| Dec 31, 2024 | 67.02 Mn |
| Sep 30, 2024 | 66.93 Mn |
| Jun 30, 2024 | 63.47 Mn |
| Mar 31, 2024 | 67.79 Mn |
| Dec 31, 2023 | 54.41 Mn |
| Sep 30, 2023 | 48.31 Mn |
| Jun 30, 2023 | 45.46 Mn |
| Mar 31, 2023 | 24.81 Mn |
| Dec 31, 2022 | 25.62 Mn |
| Sep 30, 2022 | 25.08 Mn |
| Jun 30, 2022 | 26.95 Mn |
| Mar 31, 2022 | 30.95 Mn |
| Dec 31, 2021 | 22.38 Mn |
| Sep 30, 2021 | 22.77 Mn |
| Jun 30, 2021 | 23.48 Mn |